News
-
-
PRESS RELEASE
EQS-Adhoc: Allane SE: Dividend proposal of the Management Board for the 2023 financial year in the amount of 20% of consolidated net profit
Allane SE Management Board proposes 20% dividend distribution from 2023 net profit to Annual General Meeting to ensure solid equity position for future growth -
-
-
PRESS RELEASE
SoftwareOne Founding Shareholders reaffirm their proposal for a reset at Board level and announce their support of Till Streichert as a new independent member
SoftwareOne's founding shareholders propose a board reset and back Till Streichert as an independent director. Legal opinion supports independence of nominees -
-
-
PRESS RELEASE
AMAG Technology Unveils New Strategic Direction, User Experience, Products Ahead of Largest Security Technology Tradeshow
AMAG Technology announces strategic shift to focus on product portfolio and customer experience. New security solutions launched to enhance partner and user interactions -
PRESS RELEASE
Bausch Health, Canada Inc. Announces First Public Drug Plan Listings for (Pr)UCERIS(R) (budesonide) Aerosol Foam to Help Address the Unmet Need for the Treatment of Mild to Moderate Distal Ulcerative Colitis in Adults
Bausch Health's UCERIS listed on public drug plans in 5 Canadian provinces. The rectal foam treats mild to moderate ulcerative colitis. Patients gaining insured access to effective treatment -
PRESS RELEASE
Bausch Health, Canada Inc. annonce les premières inscriptions de la mousse en aérosol (Pr)UCERIS(MC) (budésonide) aux listes des médicaments remboursés par les régimes d’assurance publics pour les adultes atteints de colite ulcéreuse distale lég
Bausch Health annonce l'inscription d'UCERIS, mousse en aérosol pour traiter la colite ulcéreuse, aux listes de médicaments remboursés par les régimes d'assurance publics de 5 provinces canadiennes
